APP and Alzheimer disease: Transgenic mice expressing variants of APP or presenilin protein carrying human familial AD-associated mutations have increasingly developed Aβ plaques and memory defects in the brain, additionally strengthening the principle that the accumulation of Aβ can cause AD (Karran et al., 2011).